Companies Dominating the Rapid Influenza Diagnostic Landscape
- Thermo Fisher Scientific Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Hologic, Inc.
- Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
- Abbott Laboratories
- BD
- F. Hoffmann-La Roche Ltd
- NeuroLogica Corp.
- GENERAL ELECTRIC
- Quest Diagnostics Incorporated
- DiaSorin SpA
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Currently in 2025, the industry revenue of rapid influenza diagnostics is estimated at USD 975.95 million.
The global rapid influenza diagnostics market is likely to rise from USD 921.75 million in 2024 to USD 2.63 billion by 2037, reflecting a CAGR of around 8.4% during the forecast timeline, from 2025 to 2037.
North America industry is set to dominate majority revenue share of 33% by 2037, due to presence of leading players in the region.
The major players in the market include of Abbott Laboratories, BD, F. Hoffmann-La Roche Ltd, NeuroLogica Corp., GENERAL ELECTRIC, Quest Diagnostics Incorporated, Shenzhen Mindray Bio-Medical Electronics Co., Ltd.,.
